The role of GCN2-kinase in antigen presenting cell function and tolerance to self
GCN2激酶在抗原呈递细胞功能和自身耐受性中的作用
基本信息
- 批准号:8662697
- 负责人:
- 金额:$ 18.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-05-16 至 2015-04-30
- 项目状态:已结题
- 来源:
- 关键词:Amino AcidsAnimal Disease ModelsAntigen PresentationAntigen-Presenting CellsAntigensApoptoticAutoimmune DiseasesAutoimmunityCCAAT-Enhancer-Binding ProteinsCell DeathCell physiologyCellsCellular StressCharacteristicsDataDefectDendritic CellsDevelopmentDioxygenasesDiseaseEnzymesExcisionGenesHalofuginoneHomologous ProteinImmuneImmune ToleranceImmune responseImmune systemImmunityImmunologicsImmunosuppressionIndividualInflammatoryLupusModelingMolecularMusOrganPathogenesisPathologyPathway interactionsPhagocytesPharmaceutical PreparationsPhosphotransferasesPlayPreventionProductionPublishingRegulatory PathwayResearchRoleSystemSystemic Lupus ErythematosusT cell responseT-LymphocyteTestingTimeTranslationsTryptophanWithdrawalbasebiological adaptation to stressblood filtercytokineindoleaminemacrophagemouse modelnovelpreventpublic health relevanceresponseskin allograftsystemic autoimmune diseasetherapeutic target
项目摘要
DESCRIPTION (provided by applicant): General control non-repressed 2 (GCN2) is a ser/thr kinase that alters translation in response to various cellular stresses. Recently we published data suggesting that GCN2 is activated in response to apoptotic cell challenge in splenic dendritic cells and macrophages controlling cytokine production, thus suggesting a novel mechanism of tolerance induction dependent on GCN2. In this proposal we will examine how GCN2 influences phagocyte responses to apoptotic cells using mice with a complete or cell specific defects in GCN2 function testing the role of GCN2 and its downstream effector C/EBP homologous protein 10 (CHOP) in apoptotic cell induced cytokine production, phagocyte maturation, antigen presentation to T cells, and ability to suppress adaptive T cell responses and induce long-term tolerance in a skin allograft model. Moreover we will examine the impact of GCN2 disruption on development of lupus in mouse models and will test the ability of the GCN2 activating drug, halofuginone, to inhibit autoimmunity development and disease pathology in animal models of the disease. Thus, the project will provide key mechanistic rationale to explore GCN2 pathway manipulation as a therapeutic target in lupus and other autoimmune diseases. !
描述(由申请人提供):通用对照非抑制 2 (GCN2) 是一种丝氨酸/苏氨酸激酶,可响应各种细胞应激而改变翻译。最近我们发表的数据表明,GCN2 在响应控制细胞因子产生的脾树突状细胞和巨噬细胞中的凋亡细胞挑战时被激活,从而提出了依赖于 GCN2 的耐受诱导的新机制。在本提案中,我们将使用 GCN2 功能完全或细胞特异性缺陷的小鼠来研究 GCN2 如何影响吞噬细胞对凋亡细胞的反应,测试 GCN2 及其下游效应器 C/EBP 同源蛋白 10 (CHOP) 在凋亡细胞诱导的细胞因子产生、吞噬细胞成熟、向 T 细胞呈递抗原以及抑制适应性 T 细胞反应的能力中的作用 并在皮肤同种异体移植模型中诱导长期耐受。此外,我们将在小鼠模型中研究 GCN2 破坏对狼疮发展的影响,并将测试 GCN2 激活药物卤常酮在动物模型中抑制自身免疫发展和疾病病理的能力。因此,该项目将为探索 GCN2 通路操纵作为狼疮和其他自身免疫性疾病的治疗靶点提供关键的机制原理。 !
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Nuclear receptors, the aryl hydrocarbon receptor, and macrophage function.
- DOI:10.1016/j.mam.2021.100942
- 发表时间:2021-04
- 期刊:
- 影响因子:10.6
- 作者:Lamorte S;Shinde R;McGaha TL
- 通讯作者:McGaha TL
Dabrafenib Alters MDSC Differentiation and Function by Activation of GCN2.
Dabrafenib 通过激活 GCN2 改变 MDSC 分化和功能。
- DOI:10.1158/2767-9764.crc-23-0376
- 发表时间:2024
- 期刊:
- 影响因子:0
- 作者:Ciudad,MTeresa;Quevedo,Rene;Lamorte,Sara;Jin,Robbie;Nzirorera,Nadine;Koritzinsky,Marianne;McGaha,TracyL
- 通讯作者:McGaha,TracyL
Apoptotic cell responses in the splenic marginal zone: a paradigm for immunologic reactions to apoptotic antigens with implications for autoimmunity.
- DOI:10.1111/imr.12382
- 发表时间:2016-01
- 期刊:
- 影响因子:8.7
- 作者:McGaha TL;Karlsson MC
- 通讯作者:Karlsson MC
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Tracy L McGaha其他文献
Ex vivo activation of the GCN2 pathway metabolically reprograms T cells, leading to enhanced adoptive cell therapy
GCN2 通路的体外激活可代谢重编程 T 细胞,从而增强过继细胞疗法
- DOI:
10.1016/j.xcrm.2024.101465 - 发表时间:
2024 - 期刊:
- 影响因子:14.3
- 作者:
M. St Paul;Samuel D. Saibil;Meghan Kates;SeongJun Han;S. Lien;Rob C Laister;K. Hezaveh;Andreas Kloetgen;Susanne Penny;Tingxi Guo;Carlos R Garcia;Logan K Smith;D. Chung;A. Elford;Azin Sayad;Devanand Pinto;Tak W Mak;Naoto Hirano;Tracy L McGaha;P. Ohashi - 通讯作者:
P. Ohashi
Tracy L McGaha的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Tracy L McGaha', 18)}}的其他基金
Mechanistic investigations of microbiome-driven aryl hydrocarbon receptor activity and macrophage function in pancreatic cancer.
胰腺癌中微生物驱动的芳烃受体活性和巨噬细胞功能的机制研究。
- 批准号:
10397510 - 财政年份:2021
- 资助金额:
$ 18.75万 - 项目类别:
Mechanistic investigations of microbiome-driven aryl hydrocarbon receptor activity and macrophage function in pancreatic cancer.
胰腺癌中微生物驱动的芳烃受体活性和巨噬细胞功能的机制研究。
- 批准号:
10611911 - 财政年份:2021
- 资助金额:
$ 18.75万 - 项目类别:
Mechanistic relationships between IDO, GCN2, and mTOR signals in immunity to apoptotic cells
IDO、GCN2 和 mTOR 信号在凋亡细胞免疫中的机制关系
- 批准号:
8858718 - 财政年份:2015
- 资助金额:
$ 18.75万 - 项目类别:
Mechanistic relationships between IDO, GCN2, and mTOR signals in immunity to apoptotic cells
IDO、GCN2 和 mTOR 信号在凋亡细胞免疫中的机制关系
- 批准号:
9031717 - 财政年份:2015
- 资助金额:
$ 18.75万 - 项目类别:
The role of marginal zone macrophages and immuno-metabolism in tumor-driven MDSC development
边缘区巨噬细胞和免疫代谢在肿瘤驱动的 MDSC 发育中的作用
- 批准号:
9183751 - 财政年份:2015
- 资助金额:
$ 18.75万 - 项目类别:
The role of marginal zone macrophages and immuno-metabolism in tumor-driven MDSC development
边缘区巨噬细胞和免疫代谢在肿瘤驱动的 MDSC 发育中的作用
- 批准号:
8886037 - 财政年份:2015
- 资助金额:
$ 18.75万 - 项目类别:
Mechanistic relationships between IDO, GCN2, and mTOR signals in immunity to apoptotic cells
IDO、GCN2 和 mTOR 信号在凋亡细胞免疫中的机制关系
- 批准号:
9268408 - 财政年份:2015
- 资助金额:
$ 18.75万 - 项目类别:
The role of GCN2-kinase in antigen presenting cell function and tolerance to self
GCN2激酶在抗原呈递细胞功能和自身耐受性中的作用
- 批准号:
8583790 - 财政年份:2013
- 资助金额:
$ 18.75万 - 项目类别:
Mechanisms of marginal zone macrophage mediated tolerance towards apoptotic cell
边缘区巨噬细胞介导的凋亡细胞耐受机制
- 批准号:
8716373 - 财政年份:2013
- 资助金额:
$ 18.75万 - 项目类别:
The role of indoleamine 2-3 dioxygenase in marginal zone-mediated tolerance
吲哚胺2-3双加氧酶在边缘区介导的耐受中的作用
- 批准号:
8301218 - 财政年份:2011
- 资助金额:
$ 18.75万 - 项目类别:
相似海外基金
Investigating how TRAF1 Controls Inflammasome Activation in Animal Disease Models of Inflammatory Arthritis and Peritonitis
研究 TRAF1 如何控制炎症性关节炎和腹膜炎动物疾病模型中的炎症小体激活
- 批准号:
449429 - 财政年份:2020
- 资助金额:
$ 18.75万 - 项目类别:
Studentship Programs
Establishment of animal disease models for intractable pediatric diseases due to defects of RNA metabolism and development of new therapeutics
RNA代谢缺陷引起的儿科疑难疾病动物模型的建立及新疗法的开发
- 批准号:
20H03644 - 财政年份:2020
- 资助金额:
$ 18.75万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Functional analysis of type 2 diabetes susceptibility genes using animal disease models
利用动物疾病模型对2型糖尿病易感基因进行功能分析
- 批准号:
18K08466 - 财政年份:2018
- 资助金额:
$ 18.75万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Cell therapy of adipocytes derived from human iPS cells using cellcontainers and animal disease models
使用细胞容器和动物疾病模型对源自人类 iPS 细胞的脂肪细胞进行细胞治疗
- 批准号:
24659444 - 财政年份:2012
- 资助金额:
$ 18.75万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Analysis of genes involved in the pathogenesis of the arthritis using animal disease models..
使用动物疾病模型分析涉及关节炎发病机制的基因。
- 批准号:
17500284 - 财政年份:2005
- 资助金额:
$ 18.75万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
ESTABLISHMENT OF THE DEVELOPING AND SUPPLING SYSTEMS FOR NEW ANIMAL,DISEASE MODELS FROM SUBSPECIES OF THE MOUSE
小鼠亚种新动物、疾病模型的开发和供应体系的建立
- 批准号:
07556128 - 财政年份:1995
- 资助金额:
$ 18.75万 - 项目类别:
Grant-in-Aid for Scientific Research (A)














{{item.name}}会员




